STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
24.13
-0.55 (-2.23%)
At close: Dec 12, 2025, 4:00 PM EST
23.65
-0.48 (-1.99%)
After-hours: Dec 12, 2025, 4:33 PM EST
STAAR Surgical Company Stock Forecast
Stock Price Forecast
The 8 analysts that cover STAAR Surgical Company stock have a consensus rating of "Hold" and an average price target of $24.56, which forecasts a 1.78% increase in the stock price over the next year. The lowest target is $16 and the highest is $30.75.
Price Target: $24.56 (+1.78%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for STAAR Surgical Company stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 8 | 8 | 8 | 8 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 8 | 8 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $28 → $31 | Hold | Maintains | $28 → $31 | +27.43% | Dec 10, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $28 → $31 | Hold | Maintains | $28 → $31 | +27.43% | Dec 10, 2025 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $20 → $28 | Strong Buy → Hold | Downgrades | $20 → $28 | +16.04% | Aug 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $20 → $28 | Hold | Maintains | $20 → $28 | +16.04% | Aug 6, 2025 |
| Sidoti & Co. | Sidoti & Co. | Strong Buy → Hold Downgrades $27 → $28 | Strong Buy → Hold | Downgrades | $27 → $28 | +16.04% | Aug 5, 2025 |
Financial Forecast
Revenue This Year
261.15M
from 313.90M
Decreased by -16.80%
Revenue Next Year
320.20M
from 261.15M
Increased by 22.61%
EPS This Year
-1.23
from -0.41
EPS Next Year
-0.09
from -1.23
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 272.9M | 361.7M | ||||
| Avg | 261.2M | 320.2M | ||||
| Low | 242.7M | 275.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -13.1% | 38.5% | ||||
| Avg | -16.8% | 22.6% | ||||
| Low | -22.7% | 5.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.00 | 0.40 | |||
| Avg | -1.23 | -0.09 | |||
| Low | -1.46 | -0.45 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.